BSE NSE
Your Result on : Company News
Glaxosmithkline Pharmaceuticals Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500660
ISIN Demat
INE159A01016
Book Value (Rs)
91.3566062
NSE Symbol
GLAXO
Divident Yield %
1.65
Market Cap
(Rs In Cr.)
32,917
P/E (TTM)
51.79
EPS (TTM)
37.52
Face Value
(Rs)
10
Date Heading
26-Mar-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
26-Mar-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
22-Mar-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
13-Mar-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
13-Mar-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
11-Mar-24 Glaxosmithkline Pharmaceuticals Ltd slips for fifth straight session
06-Mar-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
06-Mar-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
29-Feb-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
27-Feb-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
27-Feb-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
23-Feb-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
23-Feb-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
22-Feb-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
22-Feb-24 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
GANESH S SHANBHAG--NSE SEBI No. AP1413003821 | BSE SEBI No. AP0109180198601
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)